These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32784475)

  • 1. Neuroprotective Effects of a Novel Inhibitor of c-Jun N-Terminal Kinase in the Rat Model of Transient Focal Cerebral Ischemia.
    Plotnikov MB; Chernysheva GA; Smolyakova VI; Aliev OI; Trofimova ES; Sherstoboev EY; Osipenko AN; Khlebnikov AI; Anfinogenova YJ; Schepetkin IA; Atochin DN
    Cells; 2020 Aug; 9(8):. PubMed ID: 32784475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective Effects of a New C-Jun N-terminal Kinase Inhibitor in the Model of Global Cerebral Ischemia in Rats.
    Plotnikov MB; Chernysheva GA; Aliev OI; Smol'iakova VI; Fomina TI; Osipenko AN; Rydchenko VS; Anfinogenova YJ; Khlebnikov AI; Schepetkin IA; Atochin DN
    Molecules; 2019 May; 24(9):. PubMed ID: 31058815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel dual NO-donating oxime and c-Jun N-terminal kinase inhibitor protects against cerebral ischemia-reperfusion injury in mice.
    Atochin DN; Schepetkin IA; Khlebnikov AI; Seledtsov VI; Swanson H; Quinn MT; Huang PL
    Neurosci Lett; 2016 Apr; 618():45-49. PubMed ID: 26923672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of IQ-1S, a selective c-Jun N-terminal kinase (JNK) inhibitor, on phenotypical and cytokine-producing characteristics in human macrophages and T-cells.
    Seledtsov VI; Malashchenko VV; Meniailo ME; Atochin DN; Seledtsova GV; Schepetkin IA
    Eur J Pharmacol; 2020 Jul; 878():173116. PubMed ID: 32315671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Inflammatory Effects and Joint Protection in Collagen-Induced Arthritis after Treatment with IQ-1S, a Selective c-Jun N-Terminal Kinase Inhibitor.
    Schepetkin IA; Kirpotina LN; Hammaker D; Kochetkova I; Khlebnikov AI; Lyakhov SA; Firestein GS; Quinn MT
    J Pharmacol Exp Ther; 2015 Jun; 353(3):505-16. PubMed ID: 25784649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective Effects of the Lithium Salt of a Novel JNK Inhibitor in an Animal Model of Cerebral Ischemia-Reperfusion.
    Schepetkin IA; Chernysheva GA; Aliev OI; Kirpotina LN; Smol'yakova VI; Osipenko AN; Plotnikov MB; Kovrizhina AR; Khlebnikov AI; Plotnikov EV; Quinn MT
    Biomedicines; 2022 Aug; 10(9):. PubMed ID: 36140222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JNK selective inhibitor, IQ-1S, protects the mice against lipopolysaccharides-induced sepsis.
    Nie Z; Xia X; Zhao Y; Zhang S; Zhang Y; Wang J
    Bioorg Med Chem; 2021 Jan; 30():115945. PubMed ID: 33340939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive activity of a new c-Jun N-terminal kinase inhibitor in spontaneously hypertensive rats.
    Plotnikov MB; Aliev OI; Shamanaev AY; Sidekhmenova AV; Anishchenko AM; Fomina TI; Rydchenko VS; Khlebnikov AI; Anfinogenova YJ; Schepetkin IA; Atochin DN
    Hypertens Res; 2020 Oct; 43(10):1068-1078. PubMed ID: 32382155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth-beta 1 contributes to isoflurane postconditioning against cerebral ischemia-reperfusion injury by regulating the c-Jun N-terminal kinase signaling pathway.
    Wang S; Yin J; Ge M; Dai Z; Li Y; Si J; Ma K; Li L; Yao S
    Biomed Pharmacother; 2016 Mar; 78():280-290. PubMed ID: 26898453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and characterization of a novel class of c-Jun N-terminal kinase inhibitors.
    Schepetkin IA; Kirpotina LN; Khlebnikov AI; Hanks TS; Kochetkova I; Pascual DW; Jutila MA; Quinn MT
    Mol Pharmacol; 2012 Jun; 81(6):832-45. PubMed ID: 22434859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, biological evaluation, and molecular modeling of 11H-indeno[1,2-b]quinoxalin-11-one derivatives and tryptanthrin-6-oxime as c-Jun N-terminal kinase inhibitors.
    Schepetkin IA; Khlebnikov AI; Potapov AS; Kovrizhina AR; Matveevskaya VV; Belyanin ML; Atochin DN; Zanoza SO; Gaidarzhy NM; Lyakhov SA; Kirpotina LN; Quinn MT
    Eur J Med Chem; 2019 Jan; 161():179-191. PubMed ID: 30347329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [JUN N-TERMINAL KINASES AND THEIR PHARMACOLOGICAL MODULATION OF ISCHE-MIC AND REPERFUSION INJURY OF THE BRAIN].
    Shvedova MV; Anfinogenova YD; Schepetkin IA; Atochin DN
    Ross Fiziol Zh Im I M Sechenova; 2017 Mar; 103(3):268-83. PubMed ID: 30199207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel c-Jun N-Terminal Kinase (JNK) Inhibitors with an 11
    Liakhov SA; Schepetkin IA; Karpenko OS; Duma HI; Haidarzhy NM; Kirpotina LN; Kovrizhina AR; Khlebnikov AI; Bagryanskaya IY; Quinn MT
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34577159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atorvastatin Attenuates Ischemia/Reperfusion-Induced Hippocampal Neurons Injury Via Akt-nNOS-JNK Signaling Pathway.
    Shao S; Xu M; Zhou J; Ge X; Chen G; Guo L; Luo L; Li K; Zhu Z; Zhang F
    Cell Mol Neurobiol; 2017 May; 37(4):753-762. PubMed ID: 27488855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitexin protects brain against ischemia/reperfusion injury via modulating mitogen-activated protein kinase and apoptosis signaling in mice.
    Wang Y; Zhen Y; Wu X; Jiang Q; Li X; Chen Z; Zhang G; Dong L
    Phytomedicine; 2015 Mar; 22(3):379-84. PubMed ID: 25837275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotection against focal ischemic brain injury by inhibition of c-Jun N-terminal kinase and attenuation of the mitochondrial apoptosis-signaling pathway.
    Gao Y; Signore AP; Yin W; Cao G; Yin XM; Sun F; Luo Y; Graham SH; Chen J
    J Cereb Blood Flow Metab; 2005 Jun; 25(6):694-712. PubMed ID: 15716857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential role of HO-1 in regulating the MLK3-MKK7-JNK3 module scaffolded by JIP1 during cerebral ischemia/reperfusion in rats.
    Song YJ; Dai CX; Li M; Cui MM; Ding X; Zhao XF; Wang CL; Li ZL; Guo MY; Fu YY; Wen XR; Qi DS; Wang YL
    Behav Brain Res; 2019 Feb; 359():528-535. PubMed ID: 30412737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotection against permanent focal cerebral ischemia by ginkgolides A and B is associated with obstruction of the mitochondrial apoptotic pathway via inhibition of c-Jun N-terminal kinase in rats.
    Wang X; Jiang CM; Wan HY; Wu JL; Quan WQ; Wu KY; Li D
    J Neurosci Res; 2014 Feb; 92(2):232-42. PubMed ID: 24327346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Momordica charantia polysaccharides could protect against cerebral ischemia/reperfusion injury through inhibiting oxidative stress mediated c-Jun N-terminal kinase 3 signaling pathway.
    Gong J; Sun F; Li Y; Zhou X; Duan Z; Duan F; Zhao L; Chen H; Qi S; Shen J
    Neuropharmacology; 2015 Apr; 91():123-34. PubMed ID: 25510970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neuroprotective effects of K252a through inhibiting MLK3/MKK7/JNK3 signaling pathway on ischemic brain injury in rat hippocampal CA1 region.
    Pan J; Zhang QG; Zhang GY
    Neuroscience; 2005; 131(1):147-59. PubMed ID: 15680699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.